Qualigen Therapeutics (NASDAQ: QLGN) announced the official launch of its C10 Cryptocurrency Asset Treasury (DAT) purchases, with buying set to begin next week.The company said it established USD settlement, bank accounts, and crypto custody but has not purchased any virtual currencies yet. Management framed the recent crypto pullback as a deleveraging event—citing $16 billion in leveraged liquidations and ~$200 billion wiped from market cap—and said Ethena’s USDe unpegging contributed ~10–15% of liquidations. CXC10 will use an 80/20 passive/active allocation, expand hedging tools, pursue strategic M&A, and promote C10 private and ETF products to grow assets under management.